Literature DB >> 17491613

[Study of vascular risk in Navarre: objectives and design. Prevalence of metabolic syndrome and of vascular risk factors].

J J Viñes1, J Díez, M J Guembe, P González, C Amézqueta, J Barba, I Sobejano, E Martínez-Vila, A M Grijalba, M Serrano, C Moreno, E Los-Arcos, D Guerrero.   

Abstract

BACKGROUND: To determine in a representative sample of the population the prevalence of risk factors and metabolic syndrome; their association with sub-clinical atherosclerotic lesions and their impact on cardiocerebrovascular disease 10 years after.
MATERIAL AND METHODS: (Phase 1) Cross sectional survey of a random sample stratified by age and sex of the population of Navarre aged between 35 and 84. Antecedents, risk factors, physical and analytical exploration. (Phase II) Ten year follow-up cohort study, in 500 exposed to MS and 500 not exposed persons, aged between 45 and 74 years; with an 82.25% power to detect a risk ratio of 2; with analytical and image markers of sub-clinical atherosclerosis. (Phase III) Follow up of vascular events at ten years.
RESULTS: The subjects recruited were 6,553; excluded or not found 871; the final sample was 5,682 (2,644 men and 3,038 women); 4,168 (73,4%) took part in the study. The prevalence of MS was 22.1% (95%CI 20.5 - 23.7) for men and 17,2% (95%CI 15.8 - 18.5) for women. The main cardiovascular RF were high compared to other geographical areas except for HDL cholesterol. The rate was 8.5% (95%CI 7.4 - 9.6) for men and 1.7% (95%CI 1.3 - 2.2)
CONCLUSIONS: There are important differences in risk between sex, being worst for men. The high figures for HDL cholesterol and the low prevalence of MS might mean a lower risk of vascular events in Navarra.

Entities:  

Mesh:

Year:  2007        PMID: 17491613

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  5 in total

1.  [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study].

Authors:  Francisco Javier Félix-Redondo; Daniel Fernández-Bergés; José Fernando Pérez; María José Zaro; Antonio García; Luis Lozano; Héctor Sanz; María Grau; Paula Alvarez-Palacios; Verónica Tejero
Journal:  Aten Primaria       Date:  2011-02-24       Impact factor: 1.137

2.  [Cardiovascular risk factors: a follow up study in a non-diabetic population].

Authors:  María Vernet Vernet; María José Sender Palacios; Esther Jovell Fernández; Encarnació Tor Figueras; Ramón Casals Riera; Pere Larrosa Sàez
Journal:  Aten Primaria       Date:  2009-08-06       Impact factor: 1.137

3.  Association of ideal cardiovascular health with cardiovascular events and risk advancement periods in a Mediterranean population-based cohort.

Authors:  Cesar I Fernandez-Lazaro; Carmen Sayon-Orea; Estefania Toledo; Conchi Moreno-Iribas; María J Guembe
Journal:  BMC Med       Date:  2022-07-05       Impact factor: 11.150

4.  Validity of type 2 diabetes diagnosis in a population-based electronic health record database.

Authors:  Conchi Moreno-Iribas; Carmen Sayon-Orea; Josu Delfrade; Eva Ardanaz; Javier Gorricho; Rosana Burgui; Marian Nuin; Marcela Guevara
Journal:  BMC Med Inform Decis Mak       Date:  2017-04-08       Impact factor: 2.796

5.  Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.

Authors:  María J Guembe; Cesar I Fernandez-Lazaro; Carmen Sayon-Orea; Estefanía Toledo; Conchi Moreno-Iribas
Journal:  Cardiovasc Diabetol       Date:  2020-11-22       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.